Koninklijke Philips N.V. (PHG)
NYSE: PHG · Real-Time Price · USD
27.23
+0.78 (2.95%)
At close: May 6, 2026, 4:00 PM EDT
27.73
+0.50 (1.84%)
After-hours: May 6, 2026, 7:48 PM EDT
Koninklijke Philips Revenue
Koninklijke Philips had revenue of 3.91B EUR in the quarter ending March 31, 2026, a decrease of -4.69%. This brings the company's revenue in the last twelve months to 17.64B, down -1.88% year-over-year. In the year 2025, Koninklijke Philips had annual revenue of 17.83B, down -1.04%.
Revenue (ttm)
17.64B EUR
Revenue Growth
-1.88%
P/S Ratio
1.27
Revenue / Employee
270,003 EUR
Employees
65,340
Market Cap
25.90B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.83B | -187.00M | -1.04% |
| Dec 31, 2024 | 18.02B | -148.00M | -0.81% |
| Dec 31, 2023 | 18.17B | 342.00M | 1.92% |
| Dec 31, 2022 | 17.83B | 671.00M | 3.91% |
| Dec 31, 2021 | 17.16B | -157.00M | -0.91% |
| Dec 31, 2020 | 17.31B | 166.00M | 0.97% |
| Dec 31, 2019 | 17.15B | -974.00M | -5.37% |
| Dec 31, 2018 | 18.12B | 341.00M | 1.92% |
| Dec 31, 2017 | 17.78B | 358.00M | 2.05% |
| Dec 31, 2016 | 17.42B | 616.00M | 3.67% |
| Dec 31, 2015 | 16.81B | -4.59B | -21.43% |
| Dec 31, 2014 | 21.39B | -599.00M | -2.72% |
| Dec 31, 2013 | 21.99B | -244.00M | -1.10% |
| Dec 31, 2012 | 22.23B | 1.24B | 5.92% |
| Dec 31, 2011 | 20.99B | -1.30B | -5.81% |
| Dec 31, 2010 | 22.29B | 2.20B | 10.92% |
| Dec 31, 2009 | 20.09B | -6.29B | -23.85% |
| Dec 31, 2008 | 26.39B | -408.00M | -1.52% |
| Dec 31, 2007 | 26.79B | 111.00M | 0.42% |
| Dec 31, 2006 | 26.68B | 1.24B | 4.86% |
| Dec 31, 2005 | 25.45B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GE HealthCare Technologies | 20.98B |
| Zimmer Biomet Holdings | 8.41B |
| Edwards Lifesciences | 6.30B |
| Smith & Nephew | 6.16B |
| STERIS | 5.83B |
| DexCom | 4.82B |
| Globus Medical | 2.94B |
| Insulet | 2.71B |
PHG News
- 14 hours ago - Philips Reports Strong Order Intake Despite Uncertain Macro Environment - Benzinga
- 17 hours ago - From jewelers to health tech, CEOs want tariff refunds as earnings take a hit - CNBC
- 22 hours ago - Koninklijke Philips Earnings Call Transcript: Q1 2026 - Transcripts
- 1 day ago - Philips Sees Strong Sales Growth in Europe - WSJ
- 1 day ago - Dutch health-tech group Philips' sales, margins beat estimates on order growth - Reuters
- 1 day ago - Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated - GlobeNewsWire
- 1 day ago - Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated - Benzinga
- 7 days ago - Koninklijke Philips NV (PHG) Shares Fall 5.7% -- GF Value Says Still Overvalued - GuruFocus